-
US Open resumes after two-hour fog delay
-
The vaccines and treatments being developed for Ebola outbreak
-
Spanish king to visit Mexican president on June 25 as ties improve
-
Ton-up Phillips stars for New Zealand against England
-
Wahi denied Canadian visa for Ivory Coast World Cup clash with Germany
-
Swiss central bank holds interest rates, with eye on currency risks
-
S.African sentenced in 'world's largest' rhino trafficking case
-
Bank of England follows Fed in holding interest rate
-
Bittersweet World Cup for Gaza's football fans
-
Trump defends Iran deal from critics he calls 'fools'
-
New heatwave disrupts trains, schools in France
-
German chemical company to cut 3,200 jobs as crisis worsens
-
Starmer's Labour rival eyes win in UK poll key to PM's fate
-
Oil falls further on Mideast deal, but Fed outlook knocks equities
-
Mexico, Korea eye World Cup knockout berths
-
Range raises $8.3M Series A to unify treasury, risk and compliance across stablecoins and fiat
-
IAEA ready to help define 'concrete steps' to implement US-Iran deal
-
Ibrahima Konate signs four-year deal with Real Madrid
-
Hegseth tells NATO US will review force presence in Europe
-
Innovations on show at Paris Vivatech fest
-
Ukraine sets Moscow refinery ablaze in biggest attack in years
-
Bird flu kills 13,000 seal pups on remote Australian island
-
Oil prices sink further as Trump signs deal to reopen Hormuz
-
South Korean lawmakers launch probe into ballot paper shortages
-
Starmer rival seeks win in UK poll pivotal to PM's fate
-
Taiwan president says hopes for $14 bn US arms sale 'as soon as possible'
-
Why are Kenyan kids burning schools and killing their classmates?
-
New wave of anti-LGBTQ laws sweeps Africa
-
Ukraine hopes renewables can Russia-proof power grid
-
Jubilant New York on guard for Knicks parade
-
What we learned after the first round of World Cup games
-
New Zealander Manu has 'no fear' of Toulouse before Top 14 semi
-
Drastic restrictions on public transport take effect in Cuba
-
Pain-riddled South Korean man fights for right to die
-
Cuba approves economic reforms to boost private sector, investment: state TV
-
India learns to live with hotter summers
-
'Retired' Wallaby Slipper, 37, set for shock international comeback
-
EU wrestles over how to tackle China export flood
-
Tartan Army takes over Boston as Scotland fans relish World Cup return
-
Comedian Jordan Klepper wishes satire was harder in age of Trump
-
Robots pour cocktails and run marathons, but still can't multitask
-
Birthright citizenship helps spark US World Cup run
-
Ghana beat Panama 1-0 in World Cup opener after injury-time winner
-
Castro gives crucial backing to Cuba reforms
-
U.S. Polo Assn. Unveils Spring-Summer 2027 Collection at the 110th Edition of Pitti Immagine Uomo
-
Driving the World's Leading Supply Chains: 9 OMP Customers Named to The 2026 Gartner Top 25
-
Deadline Extended for 2026 Semmelweis-Richter Journalism Award Applications
-
Tuchel team talk transformed 'nervy' England in World Cup win
-
Historic World Cup goal brings rare joy to DR Congo Ebola epicentre
-
Korea coach slams 'unfortunate' drone incident at training
Deadline Extended for 2026 Semmelweis-Richter Journalism Award Applications
Following strong interest and numerous requests, the application deadline for the 2026 Semmelweis-Richter Journalism Award has been extended by two weeks. Submissions are now accepted until June 23, 2026, 23:59 CET.
BUDAPEST, HU / ACCESS Newswire / June 18, 2026 / Building on the success of its inaugural edition, the award continues to recognise outstanding journalism that contributes to public understanding of key health issues and fosters informed discussion across Europe. The initiative is organised by Semmelweis University, Hungary's leading medical and health sciences institution, in partnership with Gedeon Richter, a Hungary-based, innovation-driven specialty pharmaceutical company.
Entries are invited in two categories: Women's Health and Pharmaceutical Strategies and Innovation, the latter placing particular emphasis on cardiovascular therapies. The organisers welcome high-quality reporting that sheds light on pressing or underrepresented health topics, addresses stigma, and supports improved awareness and treatment.
The first edition drew significant international attention, with close to 70 submissions from more than 20 European countries. Articles published in prominent outlets such as The Times, The Guardian, La República, and Süddeutsche Zeitung were among those entered, highlighting the award's broad reach and relevance.
Eligibility remains unchanged for the extended deadline. Submitted articles must have been published between March 1, 2025, and March 31, 2026. Each applicant may submit up to two pieces, with a maximum of one entry per category. Submissions should be provided as scanned copies (for print), publicly accessible links (for online content), or screenshots in the case of paywalled articles. All materials must be in English or accompanied by an English translation, alongside the original version.
Applications can be submitted via the official website:
https://semmelweisrichteraward.com/
An expert jury will assess entries based on journalistic excellence, depth of research, originality, societal impact, and clarity of communication.
The total prize fund amounts to €45,000, with awards granted in both categories: €10,000 for first place, €7,500 for second, and €5,000 for third. The winners will be announced in the final week of July 2026.
All six award recipients will be invited to attend the official ceremony in October 2026 at Semmelweis University in Budapest, with travel and accommodation fully covered.
Contact:
Mr. Róbert Cseszregi
+36300164502
[email protected]
SOURCE: Gedeon Richter Plc.
View the original press release on ACCESS Newswire
R.Adler--BTB